OpenAlex
PricingAboutJobs
Log inGet started
Work

PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4 -Mutated Cancers

HTML

Year: 2025
Type: article
Source: Cancer Research
DOI: 10.1158/0008-5472.can-25-1141
Authors: Michael Hulse, Min Wang, Chaoyi Xu, Jack Carter, Anjana Agarwal, Liang Lu, Philip Pitis, Neha Bhagwat, Joseph Rager, Justin Kurian, Corey Basch, Monisha Sivakumar, Jessica Burtell, Arpita Mondal, Alexander Grego, Andrew Moore, Carly Bachner, Komali Vykuntam, Anthony Reichelderfer, Jimin Park, Joy Cote, Miles Cowart, Olusola Peace Osinubi, Ludovic Bigot, Alice Da Silva, Catline Nobre, Melissandre Meteau, Miguel Soares, Hsin-Yao Tang, Klare Bersch, Chaofeng Dai, Ganfeng Cao, Bo Shen, Tom Emm, Stefan Ruepp, Jennifer Xavier, Chris Tankersley, Diane Heiser, Sang Hyun Lee, Sandy Geeganage, Bruce Ruggeri, Hong Lin, William Novotny, Jane Huang, Kris Vaddi, Andrew Combs, Peggy Scherle, Koichi Ito
Institutions: Prelude Therapeutics Incorporated (United States), Inserm, Université Paris-Saclay, Institut Gustave Roussy, The Wistar Institute, PreludeDx (United States)
Language: English

Topic: Protein Degradation and Inhibitors
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4414465618
FWCI: 5.556
Cites: 42
Cited by: 22
Related to:
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms